GEODE CAPITAL MANAGEMENT, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 71 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$1,552,000
-30.8%
336,136
-47.5%
0.00%
Q4 2018$2,242,000
-28.8%
640,628
+105.2%
0.00%
-100.0%
Q3 2018$3,147,000
+44.1%
312,250
+3.5%
0.00%0.0%
Q2 2018$2,184,000
+44.3%
301,748
+20.4%
0.00%
Q1 2018$1,514,000
-35.9%
250,715
+2.1%
0.00%
-100.0%
Q4 2017$2,363,000
+3.5%
245,665
-4.5%
0.00%0.0%
Q3 2017$2,284,000
-28.4%
257,318
+2.0%
0.00%0.0%
Q2 2017$3,190,000
-0.5%
252,198
-17.3%
0.00%0.0%
Q1 2017$3,206,000
+25.3%
305,044
+9.7%
0.00%0.0%
Q4 2016$2,558,000
+18.7%
278,131
+52.1%
0.00%0.0%
Q3 2016$2,155,000
-8.5%
182,840
+0.5%
0.00%0.0%
Q2 2016$2,354,000
-17.0%
182,001
+2.6%
0.00%
-50.0%
Q1 2016$2,837,000
-40.5%
177,465
+6.5%
0.00%
-33.3%
Q4 2015$4,769,000
-3.4%
166,604
-3.9%
0.00%0.0%
Q3 2015$4,936,000
-7.3%
173,451
+17.0%
0.00%0.0%
Q2 2015$5,325,000
+31.9%
148,265
+113.4%
0.00%
+50.0%
Q1 2015$4,038,000
+47.4%
69,475
+6.9%
0.00%0.0%
Q4 2014$2,739,000
+23.1%
64,988
+13.2%
0.00%
+100.0%
Q3 2014$2,225,000
+55.6%
57,407
+25.3%
0.00%0.0%
Q2 2014$1,430,000
-38.6%
45,825
-18.5%
0.00%
-50.0%
Q1 2014$2,330,000
-0.3%
56,246
-6.9%
0.00%0.0%
Q4 2013$2,338,000
+78.1%
60,427
+61.1%
0.00%
+100.0%
Q3 2013$1,313,000
+342.1%
37,517
+74.9%
0.00%
Q2 2013$297,00021,4470.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2013
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders